Clinical Trial: An Open-Label, Double-Treatment Group Study to Evaluate the Efficacy and Safety of Human Allogeneic Bone-Marrow- Derived Mesenchymal Stromal Cell Product StromaForte Compared With Hyaluronic Acid for the Treatment of Knee Osteoarthritis

U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07542808) titled 'An Open-Label, Double-Treatment Group Study to Evaluate the Efficacy and Safety of Human Allogeneic Bone-Marrow- Derived Mesenchymal Stromal Cell Product StromaForte Compared With Hyaluronic Acid for the Treatment of Knee Osteoarthritis' on April 15.

Brief Summary: StromaForte injection for knee OA

Study Start Date: April 27

Study Type: INTERVENTIONAL

Condition: Knee Arthritis Osteoarthritis

Intervention: OTHER: Mesenchymal Stem Cells (MSC)

StromaForte

OTHER: Hyaluronic Acid (HA)

Hyaluronic Acid

Recruitment Status: RECRUITING

Sponsor: Cellcolabs Clinical SPV Limited

Disclaimer: Curated by HT Syndication....